https://www.symatese.com/ 2026-10-07T13:08:21+00:00 https://www.symatese.com/news/symatese-discover-our-strong-presence-at-imcas-2024/ 2024-01-30T11:35:17+00:00 https://www.symatese.com/news/symatese-device-is-at-pharmapack-2024/ 2024-01-30T11:35:44+00:00 https://www.symatese.com/news/more-good-news-from-symatese-to-jump-into-2024/ 2024-01-30T11:36:41+00:00 https://www.symatese.com/news/symatese-enters-into-exclusive-licensing-agreement-with-evolus/ 2024-01-30T11:37:32+00:00 https://www.symatese.com/news/the-effectiveness-of-collapatii-in-pediatrics/ 2024-01-30T11:37:57+00:00 https://www.symatese.com/news/successful-event-at-eba-for-symatese/ 2024-01-30T11:40:36+00:00 https://www.symatese.com/news/symatese-device-awarded-by-france-relance/ 2024-01-30T11:41:24+00:00 https://www.symatese.com/news/symatese-at-the-20th-eba-congress/ 2024-01-30T11:42:10+00:00 https://www.symatese.com/news/symatese-confirms-its-ambitions-by-opening-its-new-industrial-site/ 2024-01-30T11:43:22+00:00 https://www.symatese.com/news/symatese-at-season-congress-london/ 2024-01-30T11:44:08+00:00 https://www.symatese.com/news/symatese-products-for-aesthetics-now-in-brazil/ 2024-01-30T11:45:11+00:00 https://www.symatese.com/news/imcas-2024-what-a-success-for-symatese/ 2024-02-15T14:37:59+00:00 https://www.symatese.com/news/evolus-talks-about-its-partnership-with-symatese-at-imcas/ 2024-03-01T11:26:36+00:00 https://www.symatese.com/news/1st-class-iii-product-under-mdr-ce-marking/ 2024-03-19T09:31:18+00:00 https://www.symatese.com/news/symatese-celebrates-10-years-with-nevelia/ 2024-04-11T09:06:19+00:00 https://www.symatese.com/news/lacrifill-a-new-dry-eye-treatment-by-nordic-pharma/ 2024-04-25T16:41:41+00:00 https://www.symatese.com/news/symatese-device-at-the-pharma-days-in-geneva/ 2024-05-06T17:06:56+00:00 https://www.symatese.com/news/symatese-announces-submission-to-u-s-fda-for-its-pre-market-approval-application-for-its-ha-dermal-fillers/ 2024-06-25T11:49:30+00:00 https://www.symatese.com/news/symatese-reaches-a-decisive-milestone/ 2024-10-31T14:59:47+00:00 https://www.symatese.com/news/pharmapack-2025/ 2025-01-03T14:47:47+00:00 https://www.symatese.com/news/symatese-previews-cold-x-technology-at-imcas/ 2025-02-07T14:29:55+00:00 https://www.symatese.com/news/symatese-secures-fda-approval-for-evolysse/ 2025-02-14T12:05:06+00:00 https://www.symatese.com/news/symatese-becomes-symatese-lab/ 2025-03-05T11:43:48+00:00 https://www.symatese.com/news/symatese-announces-the-commercial-launch-of-evolysse-in-the-us/ 2025-04-17T16:00:17+00:00 https://www.symatese.com/news/symatese-accelerates-global-expansion-ambitious-growth-strategy/ 2025-05-16T16:17:59+00:00 https://www.symatese.com/news/symatese-launches-its-estyme-injectable-range-in-france/ 2025-05-28T14:04:46+00:00 https://www.symatese.com/news/imcas-2026-here-we-come/ 2026-01-16T09:43:20+00:00 https://www.symatese.com/news/symatese-speaks-out-in-the-current-debate-on-aesthetic-medicine/ 2026-02-17T17:13:39+00:00 https://www.symatese.com/news/symatese-and-nordic-pharma-reinforce-partnership/ 2026-02-23T16:53:39+00:00 https://www.symatese.com/news/symatese-expands-into-australia-canada-and-new-zealand/ 2026-08-04T15:23:55+00:00